Laurence Madera

Company: Zymeworks

Job title: Senior Scientist

Seminars:

Pairing Zymeworks’ Topoisomerase 1-inhibitor Linker-Payload with the Appropriate ADC Target, Antigen, & Indication 11:45 am

Zymeworks is focused on applying its ADC technologies for the treatment of patients suffering from diseases with high unmet need Integrated consideration of the antibody, linker-payload, indication, and target compatibility are important in the design of antibody drug conjugates Factors considered in the design of Zymeworks’ Topoisomerase 1-inhibitor ADC candidates ZW191, ZW220 and ZW251 will…Read more

day: Day One